X-Bi­otix sus­pends R&D ef­forts amid dearth of fi­nanc­ing for an­tibi­otics re­search; Ver­tex picks a pain drug for mid-stage stud­ies

Lament­ing the dearth of fi­nanc­ing avail­able for an­tibi­otics re­search de­spite a grow­ing de­mand for new prod­ucts to fight drug re­sis­tance, lit­tle Waltham, MA-based X-Bi­otix has …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER